 | • レポートコード：MRC2206A024 • 出版社/出版日：Persistence Market Research / 2022年3月25日 • レポート形態：英文、PDF、278ページ • 納品方法：Eメール • 産業分類：医薬品 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Site Licence | ￥1,124,800 (USD7,600) | ▷ お問い合わせ |
| Enterprisewide | ￥1,568,800 (USD10,600) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Persistence Market Research社の本調査レポートでは、世界の経口固形製剤（OSD）受託製造市場について広く調査・分析し、エグゼクティブサマリー、市場概要、主要市場動向、主要成功要因、市場背景、新型コロナウイルス感染症による危機分析、需要分析・予測、形状別（錠剤、カプセル、ソフトジェル、粉末・顆粒、その他）分析、メカニズム別（即時放出、遅延放出、制御放出）分析、用途別（医薬品開発、製品製造、包装/ラベリング、その他）分析、エンドユーザー別（製薬・バイオテクノロジー企業、栄養補助食品会社）分析、地域別分析、市場構造分析、競争分析、仮定、調査手法などの項目を掲載しております。 ・エグゼクティブサマリー ・市場概要 ・主要市場動向 ・主要成功要因 ・市場背景 ・新型コロナウイルス感染症による危機分析 ・需要分析・予測 ・世界の経口固形製剤（OSD）受託製造市場規模：形状別（錠剤、カプセル、ソフトジェル、粉末・顆粒、その他） ・世界の経口固形製剤（OSD）受託製造市場規模：メカニズム別（即時放出、遅延放出、制御放出） ・世界の経口固形製剤（OSD）受託製造市場規模：用途別（医薬品開発、製品製造、包装/ラベリング、その他） ・世界の経口固形製剤（OSD）受託製造市場規模：エンドユーザー別（製薬・バイオテクノロジー企業、栄養補助食品会社） ・世界の経口固形製剤（OSD）受託製造市場規模：地域別 ・市場構造分析 ・競争分析 ・仮定 ・調査手法 |
Oral Solid Dosage Contract Manufacturing Market: Scope of Report
The latest publication by Persistence Market Research on the global oral solid dosage contract manufacturing market evaluates the opportunities and current market landscape and provides detailed analysis and updates about corresponding sections affecting the market. The study offers detailed insights on current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2022-2032.
Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research’s study. This research study can support readers to know the demand for oral solid dosage contract manufacturing products and the quantitative development opportunities during the study period.
The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the oral solid dosage contract manufacturing market. Insights and information presented in this Persistence Market Research study can be leveraged by shareholders in the oral solid dosage contract manufacturing market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.
Market statistics, as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the oral solid dosage contract manufacturing market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.
Key Market Segments
Persistence Market Research’s study on the oral solid dosage contract manufacturing market offers information divided into five important segments – dosage form, mechanism, application, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.
Dosage Form
Tablets
Conventional Release
Modified Release
Chewable Tablets
Effervescent Tablets
Capsules
Hard Gelatin Capsules
Soft Gelatin
Capsules/Softgels
Powders & Granules
Lozenges & Pastilles
Gummies
Mechanism
Immediate Release
Delayed Release
Controlled Release
Application
Drug Product Development
Fill & Finish Product Manufacturing
Packaging /Labelling
Others
End User
Big Pharma/Biotech Companies
Small- & Medium-size Pharma/Biotech Companies
Emerging/Virtual Pharma Companies
Nutraceutical Companies
Region
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa
Key Questions Answered in Report
Which regions will continue to remain the most profitable markets for oral solid dosage contract manufacturing over the coming years?
How will changing trends impact the market?
How has the COVID-19 crisis impacted market growth?
How can market players capture the low-hanging opportunities in developed regions?
What are the strategies of stakeholders in the market to shape their position in this landscape?
What are the restraining factors that investors need to be aware of and might tackle while investing in the market?
What are the developmental trends that will impact the market?
How can companies in the oral solid dosage contract manufacturing market avail themselves the growth opportunities in developed and emerging sectors?
Research Methodology
In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of the oral solid dosage contract manufacturing market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts to ensure the accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market and makes Persistence Market Research’s projections on the growth prospects of the oral solid dosage contract manufacturing market are more accurate and reliable.
レポート目次1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Technology Roadmap
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Pipeline Assessment
4.2. Particle Engineering in Solid Dosage Formulation: Case Studies & Best Practices
4.3. Key Strategies Adopted by market players
4.4. Porters Analysis
4.5. PESTLE Analysis
4.6. Recent Product Launches and Approvals
4.7. Key Regulations
4.8. Value Chain Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Outlook
5.2. Forecast Factors – Relevance & Impact
5.2.1. COVID-19 Pandemic
5.2.2. Rising Geriatric Population
5.2.3. Rising Incidence of Chronic Diseases
5.2.4. Patent Expiry and Demand for Generic Drugs
5.2.5. Regulatory Policies
5.2.6. Advancement in service development
5.2.7. Service Availability in different regions
5.2.8. Market Consolidation
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunities
6. COVID19 Crisis Analysis
6.1. Current Perspectives on Coronavirus Outbreak
6.2. Current Economic Outlook & Recovery Scenario
6.3. Economic Impact of COVID-19
6.4. COVID-19: 2021 Market Scenario
7. Global Oral Solid Dosage Contract Manufacturing Market Demand (in Value or Size in US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032
7.1. Historical Market Value (US$ Mn) Analysis, 2017-2021
7.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Opportunity Analysis, 2022–2032
8. Global Oral Solid Dosage Contract Manufacturing Market Analysis 2017–2021 and Forecast 2022–2032, By Dosage Form
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) & Analysis By Dosage Form, 2017-2021
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Dosage Form, 2022–2032
8.3.1. Tablets
8.3.1.1. Conventional Release
8.3.1.2. Modified Release
8.3.1.3. Chewable Tablets
8.3.1.4. Effervescent Tablets
8.3.2. Capsules
8.3.2.1. Hard Gelatin Capsules
8.3.2.2. Soft Gelatin
8.3.3. Capsules/Softgels
8.3.4. Powders & Granules
8.3.5. Lozenges & Pastilles
8.3.6. Gummies
8.4. Market Attractiveness Analysis By Dosage Form
9. Oral Solid Dosage Contract Manufacturing Market Analysis 2017–2021 and Forecast 2022–2032, by Mechanism
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis Mechanism, 2017-2021
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Mechanism, 2022–2032
9.3.1. Immediate Release
9.3.2. Delayed Release
9.3.3. Controlled Release
9.4. Market Attractiveness Analysis By Mechanism
10. Oral Solid Dosage Contract Manufacturing Market Analysis 2017–2021 and Forecast 2022–2032, by Application
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Application, 2017-2021
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2022–2032
10.3.1. Drug Product Development
10.3.2. Fil & Finish Product Manufacturing
10.3.3. Packaging /Labelling
10.3.4. Others
10.4. Market Attractiveness Analysis By Application
11. Oral Solid Dosage Contract Manufacturing Market Analysis 2017–2021 and Forecast 2022–2032, by End User
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By End User, 2017-2021
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022–2032
11.3.1. Big Pharma/Biotech Companies
11.3.2. Small & Medium Size Pharma/Biotech Companies
11.3.3. Emerging/virtual Pharma Companies
11.3.4. Nutraceutical Companies
11.4. Market Attractiveness Analysis By End User
12. Oral Solid Dosage Contract Manufacturing Market Analysis 2017–2021 and Forecast 2022–2032, by Region
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) Analysis By Region, 2017-2021
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2022–2032
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. East Asia
12.3.5. South Asia
12.3.6. Oceania
12.3.7. Middle East and Africa
12.4. Market Attractiveness Analysis By Region
13. North America Oral Solid Dosage Contract Manufacturing Market Analysis 2017–2021 and Forecast 2022–2032
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2021
13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032
13.3.1. By Country
13.3.1.1. U.S.
13.3.1.2. Canada
13.3.2. By Dosage Form
13.3.3. By Mechanism
13.3.4. By Application
13.3.5. By End User
13.4. Market Attractiveness Analysis
13.5. Drivers and Restraints – Impact Analysis
14. Latin America Oral Solid Dosage Contract Manufacturing Market Analysis 2017–2021 and Forecast 2022–2032
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2021
14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032
14.3.1. By Country
14.3.1.1. Brazil
14.3.1.2. Mexico
14.3.1.3. Argentina
14.3.1.4. Rest of Latin America
14.3.2. By Dosage Form
14.3.3. By Mechanism
14.3.4. By Application
14.3.5. By End User
14.4. Market Attractiveness Analysis
14.5. Drivers and Restraints – Impact Analysis
15. Europe Oral Solid Dosage Contract Manufacturing Market Analysis 2017–2021 and Forecast 2022–2032
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2021
15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032
15.3.1. By Country
15.3.1.1. Germany
15.3.1.2. Italy
15.3.1.3. France
15.3.1.4. U.K.
15.3.1.5. Spain
15.3.1.6. Netherlands
15.3.1.7. Russia
15.3.1.8. Rest of Europe
15.3.2. By Dosage Form
15.3.3. By Mechanism
15.3.4. By Application
15.3.5. By End User
15.4. Market Attractiveness Analysis
15.5. Drivers and Restraints – Impact Analysis
16. South Asia Oral Solid Dosage Contract Manufacturing Market Analysis 2017–2021 and Forecast 2022–2032
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2021
16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032
16.3.1. By Country
16.3.1.1. India
16.3.1.2. Thailand
16.3.1.3. Indonesia
16.3.1.4. Malaysia
16.3.1.5. Rest of South Asia
16.3.2. By Dosage Form
16.3.3. By Mechanism
16.3.4. By Application
16.3.5. By End User
16.4. Market Attractiveness Analysis
16.5. Drivers and Restraints – Impact Analysis
17. East Asia Oral Solid Dosage Contract Manufacturing Market Analysis 2017–2021 and Forecast 2022–2032
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2021
17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032
17.3.1. By Country
17.3.1.1. China
17.3.1.2. Japan
17.3.1.3. South Korea
17.3.2. By Dosage Form
17.3.3. By Mechanism
17.3.4. By Application
17.3.5. By End User
17.4. Market Attractiveness Analysis
17.5. Drivers and Restraints – Impact Analysis
18. Oceania Oral Solid Dosage Contract Manufacturing Market Analysis 2017–2021 and Forecast 2022–2032
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2021
18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032
18.3.1. By Country
18.3.1.1. Australia
18.3.1.2. New Zealand
18.3.2. By Dosage Form
18.3.3. By Mechanism
18.3.4. By Application
18.3.5. By End User
18.4. Market Attractiveness Analysis
18.5. Drivers and Restraints – Impact Analysis
19. Middle East and Africa Oral Solid Dosage Contract Manufacturing Market Analysis 2017–2021 and Forecast 2022–2032
19.1. Introduction
19.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2021
19.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032
19.3.1. By Country
19.3.1.1. GCC Countries
19.3.1.2. Turkey
19.3.1.3. South Africa
19.3.1.4. Rest of Middle East and Africa
19.3.2. By Dosage Form
19.3.3. By Mechanism
19.3.4. By Application
19.3.5. By End User
19.4. Market Attractiveness Analysis
19.5. Drivers and Restraints – Impact Analysis
20. Market Structure Analysis
20.1. Market Analysis by Tier of Companies
20.2. Market Share Analysis of Top Players
20.3. Market Presence Analysis
20.3.1. Regional Footprint by Players
20.3.2. Product Foot print by Players
21. Competition Analysis
21.1. Competition Dashboard
21.2. Competition Benchmarking
21.3. Competition Deep Dive
21.3.1. Recipharm AB
21.3.1.1. Overview
21.3.1.2. Product Portfolio
21.3.1.3. Strategy Overview
21.3.2. AbbVie
21.3.2.1. Overview
21.3.2.2. Product Portfolio
21.3.2.3. Strategy Overview
21.3.3. Patheon N.V. (Thermo Fisher Scientific)
21.3.3.1. Overview
21.3.3.2. Product Portfolio
21.3.3.3. Strategy Overview
21.3.4. Catalent Inc.
21.3.4.1. Overview
21.3.4.2. Product Portfolio
21.3.4.3. Strategy Overview
21.3.5. NextPharma
21.3.5.1. Overview
21.3.5.2. Product Portfolio
21.3.5.3. Strategy Overview
21.3.6. Capsugel (Lonza Group AG)
21.3.6.1. Overview
21.3.6.2. Product Portfolio
21.3.6.3. Strategy Overview
21.3.7. Aurobindo Pharma Limited
21.3.7.1. Overview
21.3.7.2. Product Portfolio
21.3.7.3. Strategy Overview
21.3.8. Siegfried AG
21.3.8.1. Overview
21.3.8.2. Product Portfolio
21.3.8.3. Strategy Overview
21.3.9. Piramal Pharma Solutions
21.3.9.1. Overview
21.3.9.2. Product Portfolio
21.3.9.3. Strategy Overview
21.3.10. Corden Pharma
21.3.10.1. Overview
21.3.10.2. Product Portfolio
21.3.10.3. Strategy Overview
21.3.11. Kremoint Pharma Pvt Ltd.
21.3.11.1. Overview
21.3.11.2. Product Portfolio
21.3.11.3. Strategy Overview
21.3.12. HERMES PHARMA GmbH
21.3.12.1. Overview
21.3.12.2. Product Portfolio
21.3.12.3. Strategy Overview
21.3.13. Medipaams India Private Limited
21.3.13.1. Overview
21.3.13.2. Product Portfolio
21.3.13.3. Strategy Overview
21.3.14. Alpex Pharma
21.3.14.1. Overview
21.3.14.2. Product Portfolio
21.3.14.3. Strategy Overview
21.3.15. Abaris Healthcare Pvt Ltd
21.3.15.1. Overview
21.3.15.2. Product Portfolio
21.3.15.3. Strategy Overview
21.3.16. Ardena Holdings N.V
21.3.16.1. Overview
21.3.16.2. Product Portfolio
21.3.16.3. Strategy Overview
21.3.17. Aphena Pharma Solutions
21.3.17.1. Overview
21.3.17.2. Product Portfolio
21.3.17.3. Strategy Overview
21.3.18. Actiza Pharmaceutical Private Limited
21.3.18.1. Overview
21.3.18.2. Product Portfolio
21.3.18.3. Strategy Overview
21.3.19. Sunwin Healthcare PVT. LTD
21.3.19.1. Overview
21.3.19.2. Product Portfolio
21.3.19.3. Strategy Overview
21.3.20. Saffron Medicare PVT. LTD
21.3.20.1. Overview
21.3.20.2. Product Portfolio
21.3.20.3. Strategy Overview
21.3.21. Kosher Pharmaceuticals
21.3.21.1. Overview
21.3.21.2. Product Portfolio
21.3.21.3. Strategy Overview
21.3.22. Dr Reddy’s Lab
21.3.22.1. Overview
21.3.22.2. Product Portfolio
21.3.22.3. Strategy Overview
21.3.23. GlaxoSmithKline Plc
21.3.23.1. Overview
21.3.23.2. Product Portfolio
21.3.23.3. Strategy Overview
21.3.24. Boehringer Ingelheim BioXcellence
21.3.24.1. Overview
21.3.24.2. Product Portfolio
21.3.24.3. Strategy Overview
21.3.25. Aenova Holding
21.3.25.1. Overview
21.3.25.2. Product Portfolio
21.3.25.3. Strategy Overview
22. Assumptions and Acronyms Used
23. Research Methodology
Table 01: Global Oral Solid Dosage Contract Manufacturing Market Size Analysis (US$ Mn) Analysis 2017-2021 and Forecast 2022 – 2032, By Dosage FormTable 02: Global Oral Solid Dosage Contract Manufacturing Market Size Analysis (US$ Mn) Analysis 2017-2021 and Forecast 2022 – 2032, By Mechanism
Table 03: Global Oral Solid Dosage Contract Manufacturing Market Size Analysis (US$ Mn) Analysis 2017-2021 and Forecast 2022 – 2032, By Application
Table 04: Global Oral Solid Dosage Contract Manufacturing Market Size Analysis (US$ Mn) Analysis 2017-2021 and Forecast 2022 – 2032, By End User
Table 05: Global Oral Solid Dosage Contract Manufacturing Market Size Analysis (US$ Mn) Analysis 2017-2021 and Forecast 2022 – 2032, By Region
Table 06: North America Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country
Table 07: North America Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Dosage Form
Table 08: North America Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Mechanism
Table 09: North America Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Application
Table 10: North America Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User
Table 11: Latin America Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country
Table 12: Latin America Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Dosage Form
Table 13: Latin America Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Mechanism
Table 14: Latin America Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Application
Table 15: Latin America Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User
Table 16: Europe Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country
Table 17: Europe Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Dosage Form
Table 18: Europe Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Mechanism
Table 19: Europe Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Application
Table 20: Europe Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User
Table 21: South Asia Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country
Table 22: South Asia Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Dosage Form
Table 23: South Asia Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Mechanism
Table 24: South Asia Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Application
Table 25: South Asia Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User
Table 26: East Asia Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country
Table 27: East Asia Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Dosage Form
Table 28: East Asia Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Mechanism
Table 29: East Asia Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Application
Table 30: East Asia Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User
Table 31: Oceania Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country
Table 32: Oceania Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Dosage Form
Table 33: Oceania Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Mechanism
Table 34: Oceania Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Application
Table 35: Oceania Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User
Table 36: Middle East & Africa (MEA) Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country
Table 37: Middle East And Africa (MEA) Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Dosage Form
Table 38: Middle East and Africa (MEA) Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Mechanism
Table 39: Middle East and Africa (MEA) Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Application
Table 40: Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User